Synaptic activation protein compositions and method
CA 2287591 A1 · Owner: Worley, Paul F. · Inventors: Brakeman, Paul R.; Worley, Paul F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are nucleotide coding sequences and polypeptide sequences for synaptic activation binding proteins that are characterized by induction in the central nervous systems following neuronal activity in rat hippocampus. Such proteins are identified by (i) substantial homology at the nucleotide or protein sequence level to specifically defined rat human or mouse coding , sequences or proteins (ii) ability to bind to and affect the activity of effector proteins in the CNS, such as metabotropic glutamate receptors (iii) , binding specificity of a particular binding sequence and (iv) presence in the , sequence of a PDZ-like domain. Nucleotides and polypeptides of the invention are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 13, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 13, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 13, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.